VIDEO: Netarsudil shows potential for treating Fuchs’ dystrophy

ByRichard L. Lindstrom, MD

ByDavid W. Mullin

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting via Zoom, Richard L. Lindstrom, MD, discusses the first prospective trial of netarsudil for the treatment of Fuchs’ dystrophy.

Published by:

Sources/Disclosures

Collapse

Source:

Healio Interviews

Disclosures: Lindstrom reports being a paid consultant to Aerie Pharmaceuticals.

Read more about

fuchs' endothelial dystrophy

netarsudil

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

• Facebook
• Twitter
• LinkedIn
• Email
• Print
• Comment